Table 2 Efficacy according to RECIST 1.0
Efficacy in patients receiving treatment (n = 78) | |||
|---|---|---|---|
n | % | ||
Response rate (evaluable n = 73) | (5 missing) | ||
Complete response | 5 | 7 | |
Partial response | 23 | 31 | |
Stable disease | 31 | 43 | |
Progressive disease or death | 14 | 19 | |
95% CI | |||
PFS rate at 9 months | 0.35 | 0.24-0.46 | |
PFS | 7.0 months | 5.0-9.1 | |
OS | 17.9 months | 14.6-21.6 | |